Specifically, the review found that compared to people on treatment plans without GLP-1, those taking the medications had 0.44% lower HbA1c (an important marker of blood sugar) and were almost twice as likely to hit the recommended HbA1c target
Dizziness may occur, particularly in patients who become dehydrated due to gastrointestinal side effects or who experience hypoglycemia in the context of concurrent medications
Missing doses Lower strength Side effects Supply problems Cost People who followed treatment closely still achieved significant weight loss, up to 18%, with tirzepatide
Not every drug is right for every person, so its essential to consider your options with a clinician
Incretin pathway signaling investigated for cAMP and downstream pathway activation in receptor models
Further reading: GLP-1 tablets vs injections Serious side effects are uncommon, but patients should know what to look out for